Sign in

CIK 0001736730

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Camp4 Therapeutics Corp

Sign in to watch
Ticker
CAMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-651-8867
Business address
100 TALCOTT AVENUE, SUITE 201, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$39,600
in 1 filing
Open-market sales, last 90 days
$2,280,864
in 3 filings

Net −$2,241,264. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Schwab Andrew J. −$2.3M Director sold 21% of stake
  2. Gold Kelly +$40K Chief Financial Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-08-03 Mandel-Brehm Josh Chief Executive Officer Purchase +6,551 $1.65 $11K 284,968
2026-04-01 Mandel-Brehm Josh Chief Executive Officer Grant or award · Stock Option (Right to Buy) +580,000 580,000
2025-12-11 Mandel-Brehm Josh Chief Executive Officer Grant or award · Stock Option (Right to Buy) +425,000 425,000
2025-09-11 Mandel-Brehm Josh Chief Executive Officer Purchase +6,060 $1.65 $10K 278,417
2025-04-01 Mandel-Brehm Josh Chief Executive Officer Grant or award · Stock Option (Right to Buy) +160,000 160,000
2024-10-15 Mandel-Brehm Josh Chief Executive Officer Conversion +605 272,357
2024-10-15 Mandel-Brehm Josh Chief Executive Officer Conversion · Series B Preferred Stock −6,791 0

Page 1 of 1 · 7 trades